0

Non-Tumorous Skin Diseases Therapeutics Market by Application and Geography - Forecast and Analysis 2020-2024

  • Published: Dec 2019
  • Pages: 157
  • SKU: IRTNTR40772
Technavio

Enjoy complimentary customisation on priority with our Enterprise License!

Get me the latest version! (includes COVID-19 impact)
Safe and Secure SSL Encrypted

info
close
  • Single:

    One user only.
    Quick & easy download option

  • Enterprise:

    Unlimited user access (Within your organization)
    Complimentary Customization Included

2500 USD

The global non-tumorous skin diseases therapeutics market size has the potential to grow by USD 12.93 billion during 2020-2024. The market’s growth momentum will accelerate throughout the forecast period.

This report provides a detailed analysis of the market by geography (Asia, Europe, North America, and ROW) and application (psoriasis, eczema, acne vulgaris, and other applications). Also, the report analyzes the market’s competitive landscape and offers information on several market vendors, including AbbVie Inc., Amgen Inc., Bausch Health Companies Inc., Eli Lilly and Co., Galderma Laboratories LP, Johnson & Johnson, Novartis AG, Pfizer Inc., Sanofi, and Sun Pharmaceutical Industries Ltd.  

What will the Non-tumorous Skin Diseases Therapeutics Market Size be in 2020?

non-tumorous-skin-diseases-therapeutics-market-size

Browse TOC and LoE with selected illustrations and example pages of non-tumorous skin diseases therapeutics market

Request a FREE sample now!

Who are the Major Non-tumorous Skin Diseases Therapeutics Vendors?

The non-tumorous skin diseases therapeutics market is currently fragmented. The degree of fragmentation will remain the same over the forecast period. Vendors are adopting different inorganic business strategies such as asset-related agreements, mergers and acquisitions, and technology partnerships to increase their market presence and sales. Pfizer Inc., Sanofi, and Sun Pharmaceutical Industries Ltd. are a few of the significant market participants.

Although the accelerating market growth momentum will offer immense business opportunities to vendors, the increasing availability of generic therapeutics at a lower cost will challenge the growth of many. To make the most of the opportunities, market vendors should focus more on the growth prospects in the fast-growing segments, while maintaining their positions in the slow-growing segments.

To help clients improve their market positions, this non-tumorous skin diseases therapeutics market forecast report provides a detailed analysis of the market leaders and offers information on the competencies and capacities of the companies. The report also covers details on the market’s competitive landscape and provides information on the products offered by various companies. This non-tumorous skin diseases therapeutics market analysis report also includes information on the upcoming trends and challenges that will influence market growth. This will help companies create strategies to make the most of their future growth opportunities.

This report provides information on the production, sustainability, and prospects of several leading non-tumorous skin diseases therapeutics companies, including:

  • AbbVie Inc.
  • Amgen Inc.
  • Bausch Health Companies, Inc.
  • Eli Lilly and Co.
  • Galderma Laboratories LP
  • Johnson & Johnson
  • Novartis AG
  • Pfizer Inc.
  • Sanofi
  • Sun Pharmaceutical Industries Ltd.    

Which are the Key Markets for Non-tumorous Skin Diseases Therapeutics?

non-tumorous-skin-diseases-therapeutics-market-share-by-region

For more insights on the market share of various regions Request for a FREE sample now!

North America accounted for the largest market share in 2019. Technical advances for accurate diagnosis, high awareness about the benefit of timely treatment, the presence of established vendors, and high healthcare spending are fueling the non-tumorous skin diseases therapeutics market growth in North America. The availability of reimbursement policies is also contributing to the market growth.

Almost 41% of the overall market’s growth will originate from North America during the forecast period. The US is the critical market for non-tumorous skin diseases therapeutics in the region. The market growth rate in this region will be slower than that of Asia over the forecast period.

What are the Major Application Segments in the Non-tumorous Skin Diseases Therapeutics Market?

non-tumorous-skin-diseases-therapeutics-market-share-by-distribution-channel

Request for a FREE sample and Get more information on the market contribution of various segments

The rising psoriasis research, growing disease burden, and increasing demand for psoriasis medicines in emerging economies are augmenting the sales of non-tumorous skin diseases therapeutics. To treat psoriasis, dermatologists are significantly prescribing combination therapeutics. The growth of the psoriasis segment is driven by the rising sales of blockbuster drugs such as HUMIRA and TREMFYA. As a result, the non-tumorous skin diseases therapeutics market growth by the psoriasis segment will be significant over the forecast period.

The growth rate of the psoriasis segment is expected to be higher compared with eczema and acne vulgaris segments over the forecast period. This report provides an accurate prediction of the contribution of all the segments to the growth of the non-tumorous skin diseases therapeutics market size.

How will Prevalence of Skin Diseases Influence Non-tumorous Skin Diseases Therapeutics Market Growth?

Psoriasis and atopic dermatitis are the most common skin conditions across the world. This is because risk factors, such as exposure to irritants and allergens; bacterial, viral, and fungal infections; and illnesses affecting kidneys, immune system, thyroid, and other body systems, associated with the mentioned conditions, are increasing. This is increasing the demand for dermatological therapeutics. In line with this factor, vendors in the global non-tumorous skin diseases therapeutics market are recording increased sales. The key players are further focusing on launching novel and advanced non-tumorous skin diseases therapeutics to ensure sustainable presence in the competitive market environment.

  • Skin diseases are a significant concern associated with public healthcare and wellbeing in developed countries across the world.
  • The healthcare expenditure in most of the developed countries is significantly higher than in the developing and underdeveloped regions.
  • The medical expenditure by patients with skin conditions is increasing because of their rising need to manage the physical, psychiatric, and social consequences of skin diseases, which is one of the critical non-tumorous skin diseases therapeutics market trends.
  • The non-tumorous skin diseases therapeutics market is recording increased sales of branded biologics and small molecules for efficient treatment of skin diseases.
  • The dermatological therapeutics market will grow at a CAGR of over 9% during 2020-2024. 

non-tumorous-skin-diseases-therapeutics-market-report

Request for a FREE sample now!

What are the Key Factors Covered in this Non-tumorous Skin Diseases Therapeutics Market Report?

  • CAGR of the market during the forecast period 2020-2024
  • Detailed information on factors that will accelerate the growth of the non-tumorous skin diseases therapeutics market during the next five years
  • Precise estimation of the global non-tumorous skin diseases therapeutics market size and its contribution to the parent market
  • Accurate predictions on upcoming trends and changes in consumer behavior
  • The growth of the non-tumorous skin diseases therapeutics industry in Asia, Europe, North America, and ROW
  • A thorough analysis of the market’s competitive landscape and detailed information on vendors
  • Comprehensive details of factors that will challenge the growth of non-tumorous skin diseases therapeutics vendors

We can help! Our analysts can customize this report to meet your requirements. Get in touch

PART 01: EXECUTIVE SUMMARY

PART 02: SCOPE OF THE REPORT

  • 2.1 Preface
  • 2.2 Currency conversion rates for US$

PART 03: MARKET LANDSCAPE

  • Market ecosystem
  • Market characteristics
  • Market segmentation analysis
  • Value chain analysis

PART 04: MARKET SIZING

  • Market definition
  • Market sizing 2019
  • Market size and forecast 2019-2024
  • Market outlook

PART 05: FIVE FORCES ANALYSIS

  • Bargaining power of buyers
  • Bargaining power of suppliers
  • Threat of new entrants
  • Threat of substitutes
  • Threat of rivalry
  • Market condition

PART 06: MARKET SEGMENTATION BY APPLICATION

  • Market segmentation by application
  • Comparison by application
  • Psoriasis - Market size and forecast 2019-2024
  • Eczema - Market size and forecast 2019-2024
  • Acne vulgaris - Market size and forecast 2019-2024
  • Other applications - Market size and forecast 2019-2024
  • Market opportunity by application

PART 07: CUSTOMER LANDSCAPE

PART 08: GEOGRAPHIC LANDSCAPE

  • Geographic segmentation
  • Geographic comparison
  • North America - Market size and forecast 2019-2024
  • Europe - Market size and forecast 2019-2024
  • Asia - Market size and forecast 2019-2024
  • ROW - Market size and forecast 2019-2024
  • Key leading countries
  • Market opportunity

PART 09: DECISION FRAMEWORK

PART 10: DRIVERS AND CHALLENGES

  • Market drivers
  • Market challenges

PART 11: MARKET TRENDS

  • Business strategies
  • Misdiagnosis of skin diseases
  • Increasing healthcare expenditure

PART 12: VENDOR LANDSCAPE

  • Overview
  • Landscape disruption
  • Competitive scenario

PART 13: VENDOR ANALYSIS

  • Vendors covered
  • Vendor classification
  • Market positioning of vendors
  • AbbVie Inc.
  • Amgen Inc.
  • Bausch Health Companies, Inc.
  • Eli Lilly and Co.
  • Galderma Laboratories LP
  • Johnson & Johnson
  • Novartis AG
  • Pfizer Inc.
  • Sanofi
  • Sun Pharmaceutical Industries Ltd.

PART 14: APPENDIX

  • Research methodology
  • List of abbreviations
  • Definition of market positioning of vendors

PART 15: EXPLORE TECHNAVIO

Research Framework

Technavio presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources. The analysts have presented the various facets of the market with a particular focus on identifying the key industry influencers. The data thus presented is comprehensive, reliable, and the result of extensive research, both primary and secondary.

TechnavioINFORMATION SOURCES

Primary sources

  • Manufacturers and suppliers
  • Channel partners
  • Industry experts
  • Strategic decision makers

Secondary sources

  • Industry journals and periodicals
  • Government data
  • Financial reports of key industry players
  • Historical data
  • Press releases
Technavio

TechnavioDATA ANALYSIS

Data Synthesis

  • Collation of data
  • Estimation of key figures
  • Analysis of derived insights

Data Validation

  • Triangulation with data models
  • Reference against proprietary databases
  • Corroboration with industry experts
Technavio

TechnavioREPORT WRITING

Qualitative

  • Market drivers
  • Market challenges
  • Market trends
  • Five forces analysis

Quantitative

  • Market size and forecast
  • Market segmentation
  • Geographical insights
  • Competitive landscape
Interested in this report?
Get your sample now!
  • What are the key global market and the regional market share?
  • What are the revenue-generating key market segments?
  • What are the key factors driving and challenging this market’s growth?
  • Who are the key market vendors and their growth strategies?
  • What are the latest trends influencing the growth of this market?
  • What are the variables influencing the market growth in the primary regions?
  • What are the factors influencing the growth of the parent market?
  • Off-the-shelf research reports
  • Reports can be tailored to meet the customer's needs
  • Trusted by more than 100 fortune 500 organizations
  • Information about the market's key drivers, trends, and challenges
  • Parent market analysis
  • Every week, 50,000 people visit our subscription platform
  • Detailed vendors report with competitive landscape
  • Covid-19 impact and recovery analysis
  • Data on revenue-generating market segments
  • Details on the market shares of various regions
  • Five-force market analysis

Certified ISO 9001 : 2015

We are ISO recognized

We are ISO 9001:2015 recognized that ensures quality services and product delivery to our clients.

We are GDPR and CCPA compliant

We are GDPR and CCPA compliant! Your transaction & personal information is protected from unauthorized use.

Safe and Secure SSL Encrypted
Technavio

info
close
  • Single:

    One user only.
    Quick & easy download option

  • Enterprise:

    Unlimited user access (Within your organization)
    Complimentary Customization Included

2500 USD

Technavio Get the report (PDF) sent to your email within minutes.

Subscribe & Save

Get lifetime access to our
Technavio Insights

Customized Report as per your Business Needs

  • Our analysts will work directly with you and understand your needs
  • Get data on specified regions or segments, competitor and Vendors
  • Data will be formatted and presented as per your requirements
  • We offer $1000 worth of FREE customization at the time of purchase

Let us help you make report more suited to your requirements.

  • Get a competitive breakdown as per your niche industry
  • Customize the data with various metrics that meet your business prerequisite
  • Understand Revenue Sources, Customers and many more
  • Details on Market Share
  • These customizations are done in a short amount of time by our analysts and industry experts
Technavio
Enquire Before Buying
17,000 reports available | Plans starting from just 5,000 USD | Get FREE trial>>